House committee delays second hearing of McNeil recall probe

WASHINGTON One day following the announcement of a second hearing regarding McNeil Consumer Healthcare recalls, the House Committee on Oversight and Government Reform on Tuesday announced the postponement of that second hearing in order “to examine the circumstances surrounding recalls of medicines recently recalled by Johnson & Johnson.”

Anew date has not been set.

Last week, McNeil Consumer Healthcare announced that four lots of Benadryl allergy ultratab tablets (100 count) and one lot of Extra Strength Tylenol rapid-release gels (50 count) would be added to its initial Jan. 15 product recall. This recall, McNeil said, is a follow-up to the product recall because the products were inadvertently omitted from the initial recall action.